Please assess the completion status of the following clinical trial:

Trial Title: Psychological, Physiological, Endocrine, and Pharmacokinetic Effects of LSD in a Controlled Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age between 25 and 65 years~2. Understanding of the German language~3. Understanding the procedures and the risks associated with the study~4. Participants must be willing to adhere to the protocol and sign the consent form~5. Participants must be willing to refrain from taking illicit psychoactive substances during the study~6. Participants must be willing to drink only alcohol-free liquids and no xanthine-containing liquids (such as coffee, black or green tea, red bull, chocolate) after midnight of the evening before the study session, as well as during the study day.~7. Participants must be willing not to drive a traffic vehicle within 48 h following LSD administration.~8. Women of childbearing potential must have a negative pregnancy test at the beginning of the study and must agree to use an effective form of birth control. Pregnancy tests are repeated before each study session.~Exclusion Criteria:~1. Chronic or acute medical condition including clinically relevant abnormality in physical exam, laboratory values, or ECG. In particular: Hypertension (\>150/95 mmHg). Personal or first-grade history of seizures. Cardiac or neurological disorder.~2. Current or previous psychotic or major affective disorder~3. Psychotic or major affective disorder in first-degree relatives~4. Relevant prior illicit drug use (except tetrahydrocannabinol (THC)-containing products) more than 10 times or any time within the previous 2 months.~5. Pregnant or nursing women.~6. Participation in another clinical trial (currently or within the last 30 days)~7. Use of medications that may interfere with the effects of the study medications (any psychiatric medications)~8. Insufficient interpersonal relationship/rapport with study physician as judged by the study physician

- Gender: ALL
- Minimum Age: 25 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Placebo, LSD (Type: OTHER): Cross-over within-subjects design with all treatment conditions tested in the same subject. This design has 1 arm but two treatment conditions in the same subject.

Based on this trial design, predict the completion outcome and termination type (if applicable).